Colorectal Cancer Screening New Tool, Convenient and Precise.

Source: Jun Zhi Biomedical Co., Ltd. ( Healthcare+ Expo- booth no.: N814)

Press Release for immediate release, Nov. 30, 2023 of Healthcare 2023

Company: Junzhi Biomedical Co., Ltd.

Contact: Mandy PENG

Mobile: 886-920668026

E-mail: [email protected]

Colorectal Cancer Screening New Tool, Convenient and Precise.

The SAA Protein Test was invented by Prof. Yu-Ju Chen, the convener of the international team of Cancer Moonshot Project. The SAA protein test has an accuracy of 91% for Colorectal Cancer screening. The technology was spun off from Academia Sinica to Junzhi Biomedical. Colorectal Cancer ranks first in Taiwan’s cancer rankings for 15 consecutive years, and the survival rate of early detection and early treatment can reach more than 90%. Cancers of the digestive system usually have no special symptoms in the early stages and are difficult to detect, so when they are discovered, they are usually already in the middle-late stages which affects the effectiveness and treatment and greatly reduces the survival rate. Now there is a new detection tool with high accuracy and convenient to inspect which is helpful for early detection and early cure of Colorectal Cancer. Prof. Yu-Ju Chen, recently honored as 2023 Taiwan Outstanding Women in Science, who expressed ”This technology can make ordinary people feel less afraid of cancer. If diagnosed early, his survival rate may be as high as 90%. The testing process is to draw one tube of blood, and then send it to a mass spectrometer to judge whether you are a cancer, a normal person, or a person with other inflammatory reactions. There is no two-day preparation time required for gastroscopy or colonoscopy, and the uncomfortable feeling brought about by invasive methods.” In addition, Dr. Deng-Chyang Wu, Senior Vice President of Kaohsiung Medical University, said “The advantage of SAA detection technology is that is does not need to do invasive detection, it can be done by a single blood draw. The second is that it is accurate enough. This technology can save many lives, because that this kind of detection can find very early cancer. In the actual clinical test, SAA Protein Test has an overall accuracy of 91% for the detection of Colorectal Cancer and 85% for the detection of Gastric Cancer.

The Accuracy of Current Commonly Used Colorectal Cancer Detection Tools is not Ideal Enough, and the Invasive Detection Method such as Colonoscopy is accompanied by Some Risk.

Cancer screening technologies and services have been available on the market for many years, but their accuracy is the most criticized. By a single blood draw, and through the purification of magnetic nanoparticles, the SAA protein is analyzed by the advanced mass spectrometer “MALDI-TOF”, and the AI biological interpretation software is used to analyze the cancer risk. Instead of using invasive endoscopy, SAA Protein Test, by the simple blood draw, is also an excellent option for early gastrointestinal cancer screening.